[144] GILEAD SCIENCES, INC. SEC Filing

Rhea-AI Filing Summary

Gilead Sciences (GILD) Form 144 notice for proposed and recent insider sales. The filing shows a proposed sale of 2,500 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $283,925 and lists 1,240,806,916 shares outstanding. The filer, identified in the sales history as Andrew Dickinson, sold 2,500 shares on 06/16/2025 for $275,425, 2,500 shares on 07/15/2025 for $277,575, and 2,500 shares on 08/15/2025 for $296,325, totaling 7,500 shares sold in the past three months. Acquisition records show the securities were restricted stock acquired on 03/10/2022 (1,981 shares) and 03/10/2024 (519 shares). The filer certifies no undisclosed material adverse information and references Rule 10b5-1 language.

Positive

• None.

Negative

• Insider dispositions: The filer sold a total of 7,500 shares across June–August 2025, which may be viewed negatively by some investors monitoring insider sales patterns.
• Ongoing selling: There is a proposed additional sale of 2,500 shares on 09/15/2025, indicating continued insider liquidity events.

Insights

Securities Analyst

TL;DR: Insider has sold 7,500 GILD shares recently; proposed 2,500-share sale is routine disclosure under Rule 144.

The sales by Andrew Dickinson are disclosed across June, July and August 2025 totaling 7,500 common shares, with a proposed additional sale of 2,500 shares on 09/15/2025. The transactions were routed through Morgan Stanley Smith Barney LLC. The filing documents that the shares originated as restricted stock grants in 2022 and 2024, which explains eligibility for Rule 144 sales once conditions are met. Given the relatively small size versus the 1.24 billion shares outstanding, these sales are unlikely to be materially dilutive or immediately valuation-changing, but they are relevant for monitoring insider disposition patterns.

Corporate Governance Expert

TL;DR: Routine insider dispositions are disclosed properly; monitor for pattern but filing itself shows standard compliance.

The Form 144 provides required disclosure: seller identity, broker, amounts, dates, and acquisition provenance (restricted stock). The signer affirms absence of undisclosed material information and references Rule 10b5-1 procedural language. From a governance perspective, the document indicates compliance with Section 144 reporting obligations. The magnitude (2,500-share proposed sale; 7,500 shares sold in three months) is small relative to total outstanding shares, reducing immediate governance concern, though repeated insider sales could be of interest to investors assessing insider confidence.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2500	283925.00	1240806916	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/10/2024	Restricted Stock	Issuer			519	03/10/2024	Not Applicable
Common	03/10/2022	Restricted Stock	Issuer			1981	03/10/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	08/15/2025	2500	296325.00
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	07/15/2025	2500	277575.00
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	06/16/2025	2500	275425.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the GILD Form 144 disclose about recent insider sales?

The filing shows Andrew Dickinson sold 2,500 shares on 06/16/2025 for $275,425, 2,500 on 07/15/2025 for $277,575, and 2,500 on 08/15/2025 for $296,325.

How many shares is the proposed sale and what is its market value?

The proposed sale is 2,500 common shares with an aggregate market value of $283,925, to be executed via Morgan Stanley Smith Barney LLC.

What is the source of the shares being sold under Rule 144?

The securities were acquired as restricted stock: 1,981 shares on 03/10/2022 and 519 shares on 03/10/2024 from the issuer.

How large are these sales relative to Gilead's outstanding shares?

The filing reports 1,240,806,916 shares outstanding; the recent 7,500-share sales and proposed 2,500-share sale are immaterial relative to that total.

Who is the broker handling the proposed sale?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.